Описание: A. General Aspects of reactive oxygen species-mediated lung diseases
1. Pathology of lung diseases affected by oxidative stress
2. Approach of smoke-related lung damage 3. The state of art of NADPH Oxidase-dependent oxidative stress in lung diseases
4. Effects of radicals on pulmonary surfactant and role of lipid in this scenario
5. Infection induced oxidation and DNA repair
6. Oxidative stress in experimental models of acute lung injury
7. Oxidative Lipidomics of Lung Diseases
B. Chronic lung diseases
8. Oxidative stress in Lung Fibrosis
9. Oxidative Stress Biomarkers in COPD
10. Oxidative stress in emphysema
11. Oxidative stress induced mitochondrial dysfunction and asthma
12. Oxidative stress in asthma and COPD
D. Other lung diseases
13. Oxidative stress in environmental lung diseases
14. Bronchopulmonary dysplasia and oxidative stress in preterm newborns
15. Effect of exogeneous chemical exposure on oxidative stress induced lung diseases
16. Pulmonary antioxidant system in acute and chronic lung injury, pulmonary fibrosis in diabetes
17.Mitochondrial alterations and oxidative stress in cystic fibrosis
E. Prevention and therapeutics
18. Flagellin/Toll-like receptor 5 response was specifically attenuated by keratin sulfate disaccharide via decreased EGFR phosphorylation in human bronchial epithelial cells\
19. Therapeutic targeting of oxidative stress and inflammation in COPD and asthma: Pharmacological intervention with phytochemicals 20. ROS: modulator of therapeutic response in non-small cell lung cancer (NSCLC)
21. Arsenic-induced lung injury in rats and its reversal by a garlic polysulfide
22. The Mitochondria-targeted Drugs for Protection of Lung Damage and Pulmonary Diseases.
23. The use of ozone as redox modulator in the treatment of chronic pulmonary disease (COPD)
24. Oxidative stress and therapeutic development in lung cancer
25.The state of art of NADPH Oxidase-dependent oxidative stress in lung diseases.
26. Pharmacological modulation of ROS impairs the airway hyper responsiveness by shifting the Th1 response in allergic inflammation induced by ovalbumin 27. Flagellin/Toll-like receptor 5 response was specifically attenuated by keratin sulfate disaccharide via decreased EGFR phosphorylation in human bronchial epithelial cells.
28. Oxidative stress in experimental models of acute lung injury.
29. Pharmacokinetics, pharmacodynamics and safety of ISO1957, a preclinical candidate possessing activity against infection.
30. Rho kinase as a therapeutic target in pulmonary vascular diseases.
31. Mesenchymal stromal cell injection protects against oxidative stress in E.coli induced lung injury in mice. 32. Phosgene induced lung damage and its amelioration by cAMP elevating compounds.
